Press Releases on February 29, 2024 - EIN Presswire - Press Release Distribution Service

Published on February 29, 2024 - 13:00 GMT

Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum ...

Long-term CNM-Au8 treatment demonstrated significant and clinically meaningful improvement of vision as measured by low contrast letter acuity (LCLA), an assessment of visual function in people living with multiple sclerosis (MS), through 35 months from …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 29, 2024 - 13:00 GMT

Bionano to Present at TD Cowen’s 44th Annual Health Care Conference

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at TD Cowen’s 44th Annual Health Care Conference on March 6, 2024. …

Distribution channels:

Published on February 29, 2024 - 13:00 GMT

Auddia Details Expected Synergies of Proposed Acquisition of Radio FM

Acquired ad revenue growth expected from improving ad market rates and optimization of programmatic CPMs Near term integration of Auddia’s AI into the Radio FM (RFM) app delivers a premium ad-free AM/FM listening experience for existing users who elect to …

Distribution channels: Companies, Technology ...

Published on February 29, 2024 - 13:00 GMT

Super League Announces Sale of Minehut Business Unit to GamerSafer

SANTA MONICA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a leading creator and publisher of content experiences and media solutions across the world’s largest immersive platforms, announced today it has sold its …

Distribution channels:

Published on February 29, 2024 - 13:00 GMT

Sagimet Biosciences to Participate in Two Upcoming Investor Conferences

SAN MATEO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 29, 2024 - 13:00 GMT

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome

REVEAL adolescent and adult trial will proceed to high dose cohort following Independent Data Monitoring Committee approval of Company’s request to initiate dose escalation; dosing of first patient in cohort two (high dose, n=3) expected in Q2 2024 REVEAL …

Distribution channels: Technology ...

Published on February 29, 2024 - 13:00 GMT

Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at ...

Preclinical Research on Full-Thickness Cutaneous Wound Healing KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 29, 2024 - 13:00 GMT

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

SOLANA BEACH, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announced today the pricing of its …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 29, 2024 - 13:00 GMT

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

$60 million financing upfront with up to an additional $64.2 million tied to exercise of milestone-driven warrants Upfront net proceeds to provide funds to conduct clinical development of cytisinicline through New Drug Application submission expected in 1H …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 29, 2024 - 13:00 GMT

Locafy Announces Partnership Agreement with diDNA to Enhance Digital Property Portfolio with Leading Advertising Technology

PERTH, Australia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Locafy Limited (Nasdaq: LCFY, LCFYW) (“Locafy” or the “Company”), a globally recognized software-as-a-service technology company specializing in programmatic “Entity-Based” search engine marketing, today …

Distribution channels:

Published on February 29, 2024 - 13:00 GMT

Momcozy Earns Top Product Awards in 2024 Maternity and Baby Care Contests

New York, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Recognition by Prestigious Organizations Solidify Brand’s Position as a Global Leader in Empowering Mothers World-renowned maternity and baby care brand Momcozy has recently added a number of prestigious industry …

Distribution channels: Consumer Goods ...

Published on February 29, 2024 - 13:00 GMT

Superior Group of Companies to Announce Fourth Quarter and Full Year 2023 Results

ST. PETERSBURG, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”) today announced that it will release the results of its operations for the fourth quarter and full year 2023 after the market close on …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on February 29, 2024 - 13:00 GMT

Akero Therapeutics to Present Topline Week 96 Results from Phase 2b HARMONY Study Investigating Efruxifermin in Patients with Pre-...

SOUTH SAN FRANCISCO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease, will hold an investor conference on Monday …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 29, 2024 - 13:00 GMT

The Children's Place Announces $78.6 Million of Interest-Free Unsecured New Financing to be Provided by Mithaq Capital and the ...

Proceeds of the New Financing from the Company’s Majority Shareholder to Be Used to Support Operations, Including Vendor and Service Provider Payments Four New Mithaq Nominees Appointed to the Board, with Turki Saleh A. AlRajhi Named Chairman-Elect During …

Distribution channels:

Published on February 29, 2024 - 13:00 GMT

VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update

2023 was a transformative year for VYNE, marked by the achievement of clinical proof-of-concept for VYN201 in vitiligo and a successful financing with a syndicate of leading institutional investors Anticipate commencing a Phase 2b trial for VYN201 and a …

Distribution channels:

Published on February 29, 2024 - 12:59 GMT

Forging Change: Breaking Barriers Through Diversity and Inclusivity Conference Makes Strides for Gender-Inclusive Solutions (Feb ...

Islamabad, February 29, 2024: Pakistani and international participants today concluded a four-day conference dedicated to driving gender-inclusive solutions to the world’s most pressing challenges, including climate resilience, entrepreneurship, and …

Distribution channels:

Published on February 29, 2024 - 12:58 GMT

Gas Turbine MRO Market to Hit $18.71B by 2030 on Sustainable Power Solutions, Environment, & Tech Advances.

The global Gas Turbine MRO Market is Growing due to the increasing adoption of gas turbines for cleaner energy generation TEXAS CITY, TEXAS, UNITED STATES, February 29, 2024 /⁨EINPresswire.com⁩/ -- According to the SNS Insider, the Gas Turbine MRO Market …

Distribution channels: Energy Industry ...

Published on February 29, 2024 - 12:57 GMT

In conversation with Alex Chisholm

As he prepares to step down as Chief Operating Officer for the Civil Service and Permanent Secretary for the Cabinet Office, Alex Chisholm will speak at the Institute for Government for his final time as a civil servant. During nearly a decade at the …

Distribution channels:

Published on February 29, 2024 - 12:57 GMT

ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That ...

ZyVersa is developing Inflammasome ASC Inhibitor IC 100, which is designed to inhibit formation of multiple types of inflammasomes, including NLRP3, and their associated ASC specks to attenuate initiation and perpetuation of damaging inflammation …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on February 29, 2024 - 12:57 GMT

Zerify Exchanges Largest Debt Holder and Essentially All Warrants to Equity

EDISON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Zerify Inc. (OTC PINK: ZRFY), a pioneer in cybersecurity specializing in secure video conferencing and endpoint security, is excited to announce the restructuring of our cap table and balance sheet in an …

Distribution channels: IT Industry ...